# First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

> **NCT06644755** · PHASE1 · RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 150 (estimated)

## Conditions studied

- Solid Tumors
- Sarcoma

## Interventions

- **DRUG:** DS-2243a

## Key facts

- **NCT ID:** NCT06644755
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06644755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06644755, "First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06644755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*